Previous Page  40 / 41 Next Page
Information
Show Menu
Previous Page 40 / 41 Next Page
Page Background

Volume 6, Issue 4 (Suppl)

Clin Pharmacol Biopharm, an open access journal

ISSN: 2167-065X

Page 94

Euro Biopharma & Ethnopharmacology 2017

November 09-11, 2017

&

6

th

International Conference and Exhibition on

November 09-11, 2017 Vienna, Austria

4

th

EUROPEAN BIOPHARMA CONGRESS

PHARMACOLOGY AND ETHNOPHARMACOLOGY

Joint Event

Sarcopoterium spinosum

: An antidiabetic medicinal plant with a novel mechanism of action

T Rosenzweig, K Rozenberg

and

N Skalka

Ariel University, Israel

S

arcopoterium spinosum

(

S. spinosum

) is an abundant plant in Israel, used by Bedouin traditional medicine for the treatment

of diabetes. In our previous studies the glucose lowering properties of this herb were validated

in vitro

and in-vivo. The

goal of this study is to clarify the mechanisms of action mediating the effects of S.spinosum on glucose uptake.

S. spinosum

facilitates glucose uptake by a unique mechanism, different from that induced by either insulin or metformin;

S. spinosum

increased glucose uptake by 3T3-L1 adipocytes in a mechanism involving Glut4 translocation, independent of AMPK or PI3K

activity. Akt activation is required to induce

S. spinosum

-dependent glucose uptake, however its mechanism of activation is

still unclear; while neither ser473 nor thr308 were phosphorylated by

S. spinosum

, translocation of Akt from cytoplasm to

membrane and nucleus was detected. In addition, substrates of Akt were phosphorylated by the extract. The hypothesis that

S.

spinosum

utilizes a different set of proteins to induce glucose uptake was supported by results demonstrating that differentiating

adipocytes respond differently to insulin and

S. spinosum

; while insulin gradually enhanced glucose uptake from the 11th day

of differentiation,

S. spinosum

increased glucose uptake from the 8th day of differentiation. In addition,

S. spinosum

and insulin

had additive effect on glucose uptake in fully differentiated adipocytes. Phosphoproteomics of serine/threonine residues

phosphorylated by

S. spinosum

followed by bioinformatic analysis indicate for the activation of insulin-receptor pathway. We

conclude that active ingredients in

S. spinosum

activate insulin signaling by a unique mechanism. Clarifying this mechanism

of action may lead to the development of new agents for the treatment of diabetes.

tovitro@ariel.ac.il

Clin Pharmacol Biopharm 2017, 6:4(Suppl)

DOI: 10.4172/2167-065X-C1-026